Results 141 to 150 of about 953 (204)

HPV‐Adjusted Feature Screening With FDR Control in Head and Neck Cancer

open access: yesBiometrical Journal, Volume 68, Issue 3, June 2026.
ABSTRACT Human papillomavirus (HPV) is a well‐established prognostic factor in head and neck (HN) cancer, with HPV‐positive patients exhibiting markedly better survival outcomes compared to their HPV‐negative counterparts. While advances in (cancer) genomics have been pivotal to precision medicine, existing gene screening methods for identifying ...
Atika Farzana Urmi   +2 more
wiley   +1 more source

Addressing Small Data Challenges in Biopharmaceutical Development and Manufacturing: A Mini Review of Multi‐Fidelity Techniques

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 6, Page 1465-1480, June 2026.
ABSTRACT The growing demand for biopharmaceutical products reflects their effectiveness in medical treatments. However, developing new biopharmaceuticals remains a major bottleneck, often taking up to a decade before market approval. Machine learning (ML) models have the potential to accelerate this process, but their success depends on access to large
Mohammad Golzarijalal   +2 more
wiley   +1 more source

Sustainable Development and Social Inclusion: Efficiency Evidence From Spain and Policy Pathways for the SDGs

open access: yesBusiness Strategy &Development, Volume 9, Issue 2, June 2026.
ABSTRACT This study examines how hospitality efficiency, sustainability and social inclusion are associated with the achievement of the Sustainable Development Goals (SDGs) in Spain's 17 autonomous communities (ACs) in 2023. Using non‐parametric efficiency analysis with bootstrap correction, quantile regression models, and Random Forest methods, an ...
José Solana‐Ibáñez   +2 more
wiley   +1 more source

Long-term efficacy and safety of low-dose rituximab in immune thrombocytopenia: a multicentre, prospective, open-label, randomised controlled trial. [PDF]

open access: yesAnn Hematol
Chen Y   +17 more
europepmc   +1 more source

Deciphering nodal burden in thyroid carcinoma: A dedicated survey of age, lymph node ratio, log odds of positive nodes, and preoperative prediction models

open access: yesJournal of Intelligent Medicine, Volume 3, Issue 2, Page 169-191, June 2026.
Abstract Evidence regarding the prognosis of thyroid carcinoma is heterogeneous, ranging from age effects and nodal burden metrics, such as lymph node ratio (LNR) and log odds of positive nodes (LODDS), to preoperative imaging models comprising ultrasound, CEUS, and radiomics.
Mennatallah Sherif   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy